ReproCELL

4978.TTSE GROWTHChemicals

Key numbers · FY ended 2026-03

Revenue¥2.2bn-25.0% YoY Operating income−¥860m—Net income (owners)−¥592m-673.1% YoY Total assets¥9.7bn-0.2% YoY EPS (basic)¥-6.25-663.1% YoY

Full financial history and reports →

Stock price4978 · View chart ↗

Open the price chart on TradingView.

Latest filings

Tue, Oct 27 · JST1 filing

15:395% STAKEReproCELL · Heights Capital Management, Inc. · 8.25% → 12.36%+4.11pp

Mon, Sep 14 · JST1 filing

15:415% STAKEReproCELL · Heights Capital Management, Inc. · 10.85% → 8.25%−2.60pp

Thu, Sep 10 · JST1 filing

15:415% STAKEReproCELL · Heights Capital Management, Inc. · 5.95% → 10.85%+4.90pp

Fri, Jul 24 · JST1 filing

15:345% STAKEReproCELL · Heights Capital Management, Inc. · 3.40% → 8.70%+5.30pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
Heights Capital Management, Inc.	12.36%	+4.11pp	2026-10-27
Merrill Lynch International	5.04%	+0.85pp	2026-09-25

Each holder's own ratio from its most recent large-shareholding report.